retatrutide phase 2 trial Triple hormone receptor agonist for metabolic dysfunction-associated steatotic liver disease: a randomized 2a Triple–Hormone-Receptor Agonist Retatrutide for Obesity

Effect of BER chitosomes and BER solution on oxidative stress and neuroinflammatory and apoptosis biomarkers in rat model of parkinsonism An imbalance in reactive species production and metabolism results in oxidative stress, apoptosis and mitochondrial dysfunction and thus dopaminergic neuronal loss in PD

Third, aesthetic outcomes suffer dramatically when significant muscle is lost alongside fat

4 A large 2025 scoping review identified hair loss as an "emerging" adverse effect worth systematic investigation, noting that most existing studies lack formal dermatologic diagnostic confirmation, meaning real-world prevalence is likely underreported

The guarantee window is 60 days regardless of supply size